Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atrioventricular Block and Cluster Headache
NCT04406259Phase 4Active, not recruiting
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Nov 2020
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of verapamil in Cluster Headache (CH), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Evaluation of the atrioventricular block at 27 months. Started Nov 2020; status: active, not recruiting.
02
Drugs
verapamil
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT04406259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04406259.